A service of StreetInsider.com

Most Popular

AAPL 140.02
C 26.20
GOOG 408.49
BAC 27.40
RIMM 69.71

Recently Added

FTR 29.86
ARDM 0.24
SLAT 0.67
LNT 25.80
NDN 26.28

Gaining Speed

ACCP 2.20
XYNH 0.01
SAPE 6.13
CSG 45.46
SNRY 0.57
36.18 -1.41 (-3.76%) ABII

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:36.18 Change:-1.41 (-3.76%) Prev Close:37.59 Open: 37.50 Days Range:35.91 – 37.50 52 Week Range: 35.25 - 78.95 Volume:19858 P/E: N/A
EPS:-7.59

Member Comments

No member comments available for ABII


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 07/04/09

Recent Alert on 06/29/09 at 8:45am
Abraxis BioScience's (ABII) ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec

Abraxis BioScience, Inc. (NASDAQ: ABII) announced the listing of ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast cancer with a... Read More

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 07/01/09 at 2:35pm
Form S-3/A Abraxis BioScience, Inc.

View AllRecent Blog Posts

Blog Posts on 04/22/09 at 5:00am
A Look at D.E. Shaw's Q408 Holdings: Just for Fun
Blog Posts on 07/20/08 at 8:12am
Spotlight on China Biomedical Investment
Blog Posts on 07/16/08 at 3:55am
Abraxis Receives China Approval for Cancer Drug